Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

7 recruiting

Enrollment reporting

Analytics

N/A
7(53.8%)
Phase 2/3
3(23.1%)
Phase 1/2
1(7.7%)
Phase 2
1(7.7%)
Phase 4
1(7.7%)
13Total
N/A(7)
Phase 2/3(3)
Phase 1/2(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT05417737Active Not Recruiting

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025

Role: collaborator

NCT06799351Phase 2/3Recruiting

Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

Role: collaborator

NCT06816095Recruiting

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

Role: collaborator

NCT07259681Recruiting

Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)

Role: collaborator

NCT07325851Recruiting

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.

Role: collaborator

NCT06706544Phase 2/3Recruiting

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Role: collaborator

NCT04936282Phase 4Active Not Recruiting

Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

Role: lead

NCT07709234Not ApplicableNot Yet Recruiting

Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue

Role: collaborator

NCT06378190Phase 1/2Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Role: collaborator

NCT07437482Not Yet Recruiting

Cancer Literacy Education and Awareness Resources for Prostate Care

Role: collaborator

NCT06792981Not ApplicableRecruiting

Evaluation of a Digital School-Based Intervention for the Primary Prevention of Eating Disorders in Pre-Adolescents (PRETA Program)

Role: collaborator

NCT06576531Not ApplicableActive Not Recruiting

Exercise and Prediabetes After Renal Transplantation

Role: collaborator

NCT07036783Not Yet Recruiting

3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study

Role: lead

NCT06635239Not ApplicableCompleted

Massive Open Online Course (MOOC) for Women With Breast Cancer

Role: collaborator

NCT06607159Not ApplicableUnknown

Childhood Obesity Prevention Project in Gran Canaria

Role: collaborator

NCT06576518Not ApplicableCompleted

Exercise Intervention in Patients With Metabolic Syndrome and Renal Disease: a Prospective Study

Role: collaborator

NCT04241978Not ApplicableCompleted

Development and Evaluation of a Web Based Decision Aid for Patients With Hip Osteoarthritis

Role: collaborator

NCT03660657Phase 2/3Terminated

Ozone Therapy in Refractory Ischemic Heart Disease.

Role: collaborator

NCT03196388Phase 2Unknown

Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer

Role: lead

All 19 trials loaded